Virios Therapeutics LLC (NASDAQ:VIRI) previous close was $7.88 while the outstanding shares total 8.30M. The firm VIRI’s shares traded lower over the last trading session, losing -4.44% on 02/11/21. The shares fell to a low of $7.34 before closing at $7.53. Intraday shares traded counted 0.19 million, which was 81.36% higher than its 30-day average trading volume of 1.03M. The stock’s Relative Strength Index (RSI) is 34.56, with weekly volatility at 9.81% and ATR at 0.70. The VIRI stock’s 52-week price range has touched low of $6.45 and a $16.71 high.
Investors have identified the Biotechnology company Virios Therapeutics LLC as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $62.50 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Is the stock of VIRI attractive?
In related news, Director, Pridgen William bought 3,500 shares of the company’s stock in a transaction that recorded on Jan 29. The purchase was performed at an average price of 7.47, for a total value of 26,145. As the purchase deal closes, the VP of Finance, Walsh Angela now bought 1,000 shares of the company’s stock, valued at 7,300. Also, Director, Pridgen William bought 1,500 shares of the company’s stock in a deal that was recorded on Dec 17. The shares were cost at an average price of 11.98 per share, with a total market value of 17,970. In the last 6 months, insiders have changed their ownership in shares of company stock by 11.20%.